• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瑞士沃州(Vaud)炎症性肠病的流行情况:一项基于人群的队列研究。

Prevalence of Inflammatory Bowel Disease in the Canton of Vaud (Switzerland): A population-based cohort study.

机构信息

Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois, Rue du Bugnon 46, CH-1011 Lausanne, Switzerland.

出版信息

J Crohns Colitis. 2008 Jun;2(2):131-41. doi: 10.1016/j.crohns.2007.10.006. Epub 2007 Dec 21.

DOI:10.1016/j.crohns.2007.10.006
PMID:21172203
Abstract

BACKGROUND AND AIMS

Because of the changing epidemiology of Inflammatory Bowel Diseases (IBD), we set out to characterize the population-based prevalence of Crohn's Disease (CD) and Ulcerative Colitis (UC) in a defined population of Switzerland.

METHODS

Adult IBD patients were identified by a cross-matched review of histological, hospital and gastroenterologist files throughout a geographical defined population (Canton of Vaud). Demographic factors statistically significantly associated with prevalence were evaluated using a stepwise Poisson regression analysis. Results were compared to IBD prevalence rates in other population-based studies and time trends were performed, based on a systematic literature review.

RESULTS

Age and sex-adjusted prevalence rates were 205.7 IBD (100.7 CD and 105.0 UC) cases per 10(5) inhabitants. Among 1016 IBD patients (519 CD and 497 UC), females outnumbered males in CD (p<0.001), but males were more represented in elderly UC patients (p=0.008). Thus, being a male was statistically associated with UC (Relative Risk (RR) 1.25; p=0.013), whereas being a female was associated with CD (RR 1.27; p=0.007). Living in an urban zone was associated with both CD and UC (RR 1.49; p<0.001, 1.63; p<0.001, respectively). From 1960 to 2005, increases in UC and CD prevalences of 2.4% (95%CI, 2.1%-2.8%; p<0.001) and 3.6% (95%CI, 3.1%-4.1%; p<0.001) per annum were found in industrialised countries.

CONCLUSIONS

Extrapolating our data to all of Switzerland yields an estimate of 12,000 IBD cases for the country, or 1 in 500 inhabitants. Our study gives support to an increase in IBD prevalence in Europe.

摘要

背景与目的

由于炎症性肠病(IBD)的流行病学变化,我们着手描述在瑞士一个特定人群中基于人群的克罗恩病(CD)和溃疡性结肠炎(UC)的患病率。

方法

通过对整个地理定义人群(沃州)的组织学、医院和胃肠病学家档案进行交叉匹配审查,确定成人 IBD 患者。使用逐步泊松回归分析评估与患病率统计学显著相关的人口统计学因素。将结果与其他基于人群的研究中的 IBD 患病率进行比较,并根据系统文献综述进行时间趋势分析。

结果

年龄和性别调整后的患病率为每 105 居民中有 205.7 例 IBD(100.7 例 CD 和 105.0 例 UC)。在 1016 例 IBD 患者(519 例 CD 和 497 例 UC)中,女性在 CD 中多于男性(p<0.001),但在老年 UC 患者中男性更为多见(p=0.008)。因此,男性在统计学上与 UC 相关(相对风险(RR)1.25;p=0.013),而女性与 CD 相关(RR 1.27;p=0.007)。居住在城市地区与 CD 和 UC 均相关(RR 1.49;p<0.001,1.63;p<0.001)。从 1960 年到 2005 年,工业化国家中 UC 和 CD 的患病率每年分别增加 2.4%(95%CI,2.1%-2.8%;p<0.001)和 3.6%(95%CI,3.1%-4.1%;p<0.001)。

结论

将我们的数据外推到瑞士全境,估计该国的 IBD 病例数为 12000 例,即每 500 居民中有 1 例。我们的研究支持欧洲 IBD 患病率的增加。

相似文献

1
Prevalence of Inflammatory Bowel Disease in the Canton of Vaud (Switzerland): A population-based cohort study.瑞士沃州(Vaud)炎症性肠病的流行情况:一项基于人群的队列研究。
J Crohns Colitis. 2008 Jun;2(2):131-41. doi: 10.1016/j.crohns.2007.10.006. Epub 2007 Dec 21.
2
Incidence of inflammatory bowel disease in five geographical areas of Uruguay in the biennial 2007-2008.2007 - 2008两年期乌拉圭五个地理区域的炎症性肠病发病率。
Acta Gastroenterol Latinoam. 2011 Dec;41(4):281-7.
3
Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.克罗恩病和溃疡性结肠炎。欧洲一项基于人群的起始队列研究中疾病第一年的发病率、病程及预后
Dan Med J. 2014 Jan;61(1):B4778.
4
Inflammatory bowel disease in Tuzla Canton, Bosnia-Herzegovina: A prospective 10-year follow-up.波斯尼亚和黑塞哥维那图兹拉州的炎症性肠病:一项前瞻性 10 年随访研究。
World J Gastroenterol. 2021 May 28;27(20):2630-2642. doi: 10.3748/wjg.v27.i20.2630.
5
[Incidence and prevalence of inflammatory bowel disease. Asturian study in 5 areas (EIICEA). Spain].[炎症性肠病的发病率和患病率。阿斯图里亚斯5个地区的研究(EIICEA)。西班牙]
An Med Interna. 2003 Jan;20(1):3-9.
6
Inflammatory Bowel Disease Environmental Risk Factors: A Population-Based Case-Control Study of Middle Eastern Migration to Australia.炎症性肠病环境风险因素:基于人群的中东移民移居澳大利亚的病例对照研究。
Clin Gastroenterol Hepatol. 2015 Aug;13(8):1453-63.e1. doi: 10.1016/j.cgh.2015.02.045. Epub 2015 Mar 11.
7
Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: a single-center cohort study.克罗恩病的瘘管形成模式和溃疡性结肠炎的全结肠炎是癌症的独立危险因素:一项单中心队列研究。
J Crohns Colitis. 2012 Jun;6(5):578-87. doi: 10.1016/j.crohns.2011.11.005. Epub 2011 Dec 20.
8
[Epidemiology of inflammatory bowel diseases in Veszprém county of Western Hungary between 1977 and 2001].1977年至2001年匈牙利西部维斯普雷姆县炎症性肠病的流行病学
Orv Hetil. 2003 Sep 14;144(37):1819-27.
9
Association of MALTectomy (appendectomy and tonsillectomy) and inflammatory bowel disease: a familial case-control study.黏膜相关淋巴组织切除术(阑尾切除术和扁桃体切除术)与炎症性肠病的关联:一项家族性病例对照研究。
Rev Esp Enferm Dig. 2001 May;93(5):303-14.
10
Inflammatory bowel disease. An epidemiological and genetic study.炎症性肠病。一项流行病学与遗传学研究。
Acta Chir Scand Suppl. 1990;559:1-42.

引用本文的文献

1
Progress in targeting the NLRP3 signaling pathway for inflammatory bowel disease (Review).靶向NLRP3信号通路治疗炎症性肠病的研究进展(综述)
Mol Med Rep. 2025 Sep;32(3). doi: 10.3892/mmr.2025.13606. Epub 2025 Jul 4.
2
Development of a Global Rating Scale for Inflammatory Bowel Disease.炎症性肠病全球评分量表的制定。
J Can Assoc Gastroenterol. 2019 Jun 11;3(1):4-16. doi: 10.1093/jcag/gwz017. eCollection 2020 Feb.
3
Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland.
用于治疗炎症性肠病患者缺铁性贫血的铁制剂:瑞士的成本效益分析。
Adv Ther. 2021 Jan;38(1):660-677. doi: 10.1007/s12325-020-01553-1. Epub 2020 Nov 20.
4
Can the CalproQuest predict a positive Calprotectin test? A prospective diagnostic study.CalproQuest 能否预测 Calprotectin 检测呈阳性?一项前瞻性诊断研究。
PLoS One. 2019 Nov 21;14(11):e0224961. doi: 10.1371/journal.pone.0224961. eCollection 2019.
5
Prevalence of Anal Fistulas in Europe: Systematic Literature Reviews and Population-Based Database Analysis.欧洲肛门瘘管的患病率:系统文献综述和基于人群的数据库分析。
Adv Ther. 2019 Dec;36(12):3503-3518. doi: 10.1007/s12325-019-01117-y. Epub 2019 Oct 26.
6
The Impact of Inflammatory Bowel Disease in Canada 2018: IBD Research Landscape in Canada.2018年炎症性肠病在加拿大的影响:加拿大炎症性肠病研究概况
J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S81-S91. doi: 10.1093/jcag/gwy057. Epub 2018 Nov 2.
7
Influence of Environmental Factors in the Development and Outcomes of Inflammatory Bowel Disease.环境因素对炎症性肠病发生发展及预后的影响
Gastroenterol Hepatol (N Y). 2019 Feb;15(2):72-82.
8
Is the emergence of inflammatory bowel disease a prime example of "the third epidemiological transition"?炎症性肠病的出现是“第三次流行病学转变”的一个典型例子吗?
Indian J Gastroenterol. 2018 May;37(3):183-185. doi: 10.1007/s12664-018-0852-y. Epub 2018 Jun 12.
9
Trends in prevalence, mortality, health care utilization and health care costs of Swiss IBD patients: a claims data based study of the years 2010, 2012 and 2014.瑞士炎症性肠病患者的患病率、死亡率、医疗保健利用情况及医疗保健费用趋势:基于2010年、2012年和2014年理赔数据的研究
BMC Gastroenterol. 2017 Dec 2;17(1):138. doi: 10.1186/s12876-017-0681-y.
10
Eosinophilic esophagitis: What can we learn from Crohn's disease?嗜酸性食管炎:我们能从克罗恩病中学到什么?
United European Gastroenterol J. 2017 Oct;5(6):762-772. doi: 10.1177/2050640616672953. Epub 2016 Sep 29.